My Blog List

Friday, 17 November 2017

Radiopharmaceuticals in Nuclear Medicine Market Estimated to Grow Strongly by 2022

Description:

This report studies Radiopharmaceuticals in Nuclear Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
By Application, the market can be split into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1150774&req_type=disc

Table of Content:

1 Industry Overview of Radiopharmaceuticals in Nuclear Medicine1.1 Definition and Specifications of Radiopharmaceuticals in Nuclear Medicine
1.1.1 Definition of Radiopharmaceuticals in Nuclear Medicine
1.1.2 Specifications of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine
1.2.1 Diagnostic Radiopharmaceuticals
1.2.2 Therapy Radiopharmaceuticals
1.2.3 Enriched Stable Isotopes
1.3 Applications of Radiopharmaceuticals in Nuclear Medicine
1.3.1 Diagnostic Application
1.3.2 Therapeutic Application
1.3.3 Research
1.3.4 Pharmaceutical
1.3.5 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine
2.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
2.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India